These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 23064471

  • 21. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
    Sakamoto K, Triplett AA, Schuler LA, Wagner KU.
    Oncogene; 2010 Sep 30; 29(39):5359-69. PubMed ID: 20639901
    [Abstract] [Full Text] [Related]

  • 22. The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.
    Fiorillo AA, Medler TR, Feeney YB, Wetz SM, Tommerdahl KL, Clevenger CV.
    Am J Pathol; 2013 Jan 30; 182(1):217-33. PubMed ID: 23159947
    [Abstract] [Full Text] [Related]

  • 23. The role of prolactin receptor in GH signaling in breast cancer cells.
    Xu J, Sun D, Jiang J, Deng L, Zhang Y, Yu H, Bahl D, Langenheim JF, Chen WY, Fuchs SY, Frank SJ.
    Mol Endocrinol; 2013 Feb 30; 27(2):266-79. PubMed ID: 23192981
    [Abstract] [Full Text] [Related]

  • 24. Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.
    Griffith OL, Chan SR, Griffith M, Krysiak K, Skidmore ZL, Hundal J, Allen JA, Arthur CD, Runci D, Bugatti M, Miceli AP, Schmidt H, Trani L, Kanchi KL, Miller CA, Larson DE, Fulton RS, Vermi W, Wilson RK, Schreiber RD, Mardis ER.
    Cell Rep; 2016 Sep 27; 17(1):249-260. PubMed ID: 27681435
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures.
    Ueda EK, Huang K, Nguyen V, Ferreira M, Andre S, Walker AM.
    Cell Tissue Res; 2011 Nov 27; 346(2):175-89. PubMed ID: 22081226
    [Abstract] [Full Text] [Related]

  • 29. Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
    Rasmussen LM, Frederiksen KS, Din N, Galsgaard E, Christensen L, Berchtold MW, Panina S.
    Endocr Relat Cancer; 2010 Sep 27; 17(3):809-22. PubMed ID: 20601496
    [Abstract] [Full Text] [Related]

  • 30. Connections between prolactin and ovarian cancer.
    Alkharusi A, AlMuslahi A, AlBalushi N, AlAjmi R, AlRawahi S, AlFarqani A, Norstedt G, Zadjali F.
    PLoS One; 2021 Sep 27; 16(8):e0255701. PubMed ID: 34358244
    [Abstract] [Full Text] [Related]

  • 31. Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
    Tan D, Chen KE, Khoo T, Walker AM.
    Cancer Lett; 2011 Nov 01; 310(1):101-8. PubMed ID: 21775057
    [Abstract] [Full Text] [Related]

  • 32. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.
    Fleenor D, Arumugam R, Freemark M.
    Horm Res; 2006 Nov 01; 66(3):101-10. PubMed ID: 16735796
    [Abstract] [Full Text] [Related]

  • 33. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
    Beck MT, Chen NY, Franek KJ, Chen WY.
    Cancer Res; 2003 Jul 01; 63(13):3598-604. PubMed ID: 12839947
    [Abstract] [Full Text] [Related]

  • 34. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
    Hachim IY, Shams A, Lebrun JJ, Ali S.
    Hum Pathol; 2016 Jul 01; 53():142-52. PubMed ID: 26980025
    [Abstract] [Full Text] [Related]

  • 35. Impaired turnover of prolactin receptor contributes to transformation of human breast cells.
    Plotnikov A, Varghese B, Tran TH, Liu C, Rui H, Fuchs SY.
    Cancer Res; 2009 Apr 01; 69(7):3165-72. PubMed ID: 19276348
    [Abstract] [Full Text] [Related]

  • 36. Bovine prolactin elevates hTF expression directed by a tissue-specific goat β-casein promoter through prolactin receptor-mediated STAT5a activation.
    Jiang S, Ren Z, Xie F, Yan J, Huang S, Zeng Y.
    Biotechnol Lett; 2012 Nov 01; 34(11):1991-9. PubMed ID: 22829284
    [Abstract] [Full Text] [Related]

  • 37. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
    Pedraz-Cuesta E, Fredsted J, Jensen HH, Bornebusch A, Nejsum LN, Kragelund BB, Pedersen SF.
    Mol Endocrinol; 2016 Jul 01; 30(7):693-708. PubMed ID: 27176613
    [Abstract] [Full Text] [Related]

  • 38. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene.
    Zhang X, Zhu T, Chen Y, Mertani HC, Lee KO, Lobie PE.
    J Biol Chem; 2003 Feb 28; 278(9):7580-90. PubMed ID: 12482855
    [Abstract] [Full Text] [Related]

  • 39. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
    Bogorad RL, Courtillot C, Mestayer C, Bernichtein S, Harutyunyan L, Jomain JB, Bachelot A, Kuttenn F, Kelly PA, Goffin V, Touraine P, Benign Breast Diseases Study Group.
    Proc Natl Acad Sci U S A; 2008 Sep 23; 105(38):14533-8. PubMed ID: 18779591
    [Abstract] [Full Text] [Related]

  • 40. Amplification of the prolactin receptor gene in mammary lobular neoplasia.
    Tran-Thanh D, Arneson NC, Pintilie M, Deliallisi A, Warren KS, Bane A, Done SJ.
    Breast Cancer Res Treat; 2011 Jul 23; 128(1):31-40. PubMed ID: 20658264
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.